Abstract
Recent advances in cDNA microarray techniques have enabled us to study the expression of many genes simultaneously. As gastric cancer remains one of the most common cancers in Japan, we studied gene expression profiles in gastric cancer by cDNA microarray analysis to determine if it would be clinically useful. We demonstrated two points. First, cDNA microarray might be useful as a prognostic indicator. However, there remain several important problems to be solved and these are discussed. Second, laser microdissection plus cDNA microarray might be useful in determining the specific genes that correlate to cancer metastasis or histological subtype. We review the pros and cons for cDNA microarray analysis in the context of gastric cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816
Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y (2002) Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62:7012
Honda M, Mori M, Ueo H, Sugimachi K, Akiyoshi T (1996) Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39:444
Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M (2002) Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res 8:3475
Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K (2002) Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 131:S39
van de Vijver MJ, He YD, van ‘t Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999
van’t Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530
Yamashita K, Upadhay S, Mimori K, Inoue H, Mori M (2003) Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression. Cancer 97:2412
Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M (2003) Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil dominant kinase messenger RNA expression and promotes cell motility. Ann Surg Oncol 10:682
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was presented at the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, “State of the Arts for Digestive Organs”, 14–15 November 2003, Nagoya, Japan.
Rights and permissions
About this article
Cite this article
Haraguchi, N., Inoue, H., Mimori, K. et al. Analysis of gastric cancer with cDNA microarray. Cancer Chemother Pharmacol 54 (Suppl 1), S21–S24 (2004). https://doi.org/10.1007/s00280-004-0882-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-004-0882-2